Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩31,750, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Medical Equipment industry in South Korea. Total returns to shareholders of 2.7% over the past three years. Major Estimate Revision • May 07
Consensus EPS estimates increase by 25%, revenue downgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from ₩264.8m to ₩260.9m. EPS estimate rose from ₩2,953 to ₩3,682. Net income forecast to grow 57% next year vs 57% growth forecast for Medical Equipment industry in South Korea. Consensus price target of ₩31,333 unchanged from last update. Share price rose 14% to ₩30,900 over the past week. Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩29,150, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Medical Equipment industry in South Korea. Total returns to shareholders of 4.6% over the past three years. Tillkännagivande • Mar 19
Vieworks Co., Ltd. Brings Next-Generation Machine Vision Solutions To Vision China Shanghai 2026 Vieworks, a prominent South Korean provider of industrial imaging solutions, is scheduled to participate in Vision China Shanghai 2026 from March 25th to 27th at Booth 5309 in Hall W5. The company's exhibit will feature a comprehensive range of industrial cameras, lenses, accessories, and industrial X-ray detectors designed for the most demanding vision applications. Building on its reputation for industry-leading high resolution cameras, Vieworks will debut the VPS-245MX2. This area scan camera utilizes thermoelectric Peltier cooling to feature an impressive 245 megapixel resolution, making it an ideal choice for high-precision tasks such as inspecting flat panel displays, printed circuit boards, and semiconductor components. The primary focus of the exhibit is the next-generation CoaXPress-over-Fiber (CoF) interface technology. Vieworks' CoF solution utilizes fiber optics to reach transmission speeds of up to 100 Gbps, effectively eliminating data bottlenecks over long distances and providing the stability required for complex applications. Vieworks will also showcase the VTS Series, the latest addition to its TDI (time delayed integration) line scan camera portfolio. By integrating back-side illuminated (BSI) sensors, these cameras achieve significantly higher quantum efficiency (QE) and a superior signal-to-noise ratio (SNR). This enhanced sensitivity ensures elite image quality across the visible, UV, and NIR spectrums, particularly in light-starved environments. In addition to its cameras, the booth will feature the VEO Series of industrial lenses. This family of high-performance optics was co-developed with Schneider Kreuznach and specifically engineered to complement the technical specifications of Vieworks' cameras. A live demonstration will highlight the VEO 10.0x lens working in tandem with a Vieworks camera and an autofocus module. The display will further include the company's latest breakthroughs in the industrial X-ray sector, specifically its flexible bendable detectors. While traditional flat panel detectors are limited by their rigid form, these bendable units enable the non-destructive testing of curved objects like industrial piping, offering the flexibility required for specialized inspection environments. To maximize image processing performance, it is essential to have technology that can acquire and transmit vast amounts of data quickly and reliably. By presenting these CoF and BSI solutions in Shanghai, the company aims to provide the critical infrastructure needed for increasingly demanding inspection markets. Industry professionals are invited to visit Booth 5309 in Hall W5 during Vision China Shanghai 2026 to see how these latest advancements are shaping the future of the global machine vision industry. Tillkännagivande • Mar 18
Vieworks to Debut VISQUE DPS LH210 at USCAP 2026 Vieworks will participate in USCAP 2026 (United States & Canadian Academy of Pathology Annual Meeting), held from March 23 to 25 at the Henry B. González Convention Center in San Antonio, Texas. At the exhibition, Vieworks will present its latest digital pathology solutions at booth 352, featuring the VISQUE DPS slide scanner lineup. The VISQUE DPS series delivers fast scanning, optimized data size, and efficient workflow performance for digital pathology, supporting both histology and cytology applications across a wide range of pathology diagnostics and research environments. A major highlight at the exhibition will be the global debut of the VISQUE DPS LH210, a mid-capacity digital slide scanner developed to meet the growing demand for efficient and scalable digital pathology systems. The LH210 supports up to 210 slides per batch and provides a fast scan speed of 23 seconds per slide (15 × 15 mm @ 40×), enabling stable productivity for laboratories that require reliable performance without requiring a large-footprint system. The scanner is designed to deliver high-resolution images with reduced file size, helping reduce storage requirements while improving data transfer efficiency across digital pathology workflows. Like the LH510 in the VISQUE DPS lineup, the LH210 incorporates Vieworks' proprietary Realtime Extended Focus (Realtime EF) technology featuring a 3-camera structure, enabling simultaneous capture of multiple focal images and real-time fusion into a single sharp, high-quality whole slide image. Through this approach, the system maintains high scanning speed while reducing file size, ensuring smooth operation in both routine and research environments. The scanner supports both cytology and histology slides on a single system, allowing laboratories to handle multiple applications with one device while simplifying workflow configuration. Also featured at the booth, the VISQUE DPS LH510 represents Vieworks' high-throughput solution designed for large hospitals, reference labs, and research centers. With its large slide capacity and stable high-speed scanning performance, LH510 is optimized for high-volume environments that require continuous scanning of large numbers of slides. Together, LH510 and LH210 demonstrate Vieworks' strategy to provide a complete digital pathology lineup covering a wide range of throughput requirements. Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩26,300, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 11x in the Medical Equipment industry in South Korea. Total loss to shareholders of 4.0% over the past three years. Tillkännagivande • Mar 10
Vieworks Co., Ltd. (KOSDAQ:A100120) announces an Equity Buyback for KRW 10,000 million worth of its shares. Vieworks Co., Ltd. (KOSDAQ:A100120) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares according to the trust contract with Samsung Securities Co., Ltd. The purpose of the program is to enhance shareholder value and stabilize stock price. The program will expire on September 9, 2026. As of March 9, 2026, the company had no shares in treasury within the scope available for dividend and no share in treasury under other repurchases. Tillkännagivande • Mar 04
Vieworks Co., Ltd., Annual General Meeting, Mar 31, 2026 Vieworks Co., Ltd., Annual General Meeting, Mar 31, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 41-3, burim-ro 170beon-gil, dongan-gu, gyeonggi-do, anyang South Korea Major Estimate Revision • Feb 14
Consensus EPS estimates increase by 45% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩255.7m to ₩270.4m. EPS estimate increased from ₩2,312 to ₩3,353 per share. Net income forecast to grow 41% next year vs 28% growth forecast for Medical Equipment industry in South Korea. Consensus price target up from ₩26,667 to ₩29,667. Share price rose 4.6% to ₩26,350 over the past week. New Risk • Feb 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.9% average weekly change). Buy Or Sell Opportunity • Feb 02
Now 22% undervalued Over the last 90 days, the stock has risen 27% to ₩23,650. The fair value is estimated to be ₩30,357, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 8.7%. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 25% in the next 2 years. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩24,900, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Medical Equipment industry in South Korea. Total loss to shareholders of 18% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩28,723 per share. Upcoming Dividend • Dec 22
Upcoming dividend of ₩600 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.1%). Price Target Changed • Nov 23
Price target decreased by 16% to ₩26,667 Down from ₩31,750, the current price target is an average from 3 analysts. New target price is 40% above last closing price of ₩19,050. Stock is down 9.3% over the past year. The company is forecast to post earnings per share of ₩1,682 for next year compared to ₩2,319 last year. Declared Dividend • Nov 08
Dividend of ₩600 announced Dividend of ₩600 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 3.3%, which is higher than the industry average of 1.8%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 12% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 110% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Nov 07
Vieworks Co., Ltd. announces Annual dividend, payable on April 13, 2026 Vieworks Co., Ltd. announced Annual dividend of KRW 600.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Price Target Changed • Jul 10
Price target decreased by 7.6% to ₩29,333 Down from ₩31,750, the current price target is an average from 3 analysts. New target price is 36% above last closing price of ₩21,500. Stock is down 23% over the past year. The company is forecast to post earnings per share of ₩2,226 for next year compared to ₩2,319 last year. Tillkännagivande • Mar 13
Vieworks Co., Ltd. (KOSDAQ:A100120) announces an Equity Buyback for KRW 5,000 million worth of its shares. Vieworks Co., Ltd. (KOSDAQ:A100120) announces a share repurchase program. Under the program, the company will repurchase up to KRW 5,000 million worth of its shares according to the trust contract with Samsung Securities Co., Ltd. The purpose of the program is to enhance shareholder value and stabilize stock price. The program will expire on September 12, 2025. As of March 12, 2025, the company had 568,089 shares in treasury within the scope available for dividend and no share in treasury under other repurchases. Tillkännagivande • Feb 27
Vieworks Co., Ltd., Annual General Meeting, Mar 31, 2025 Vieworks Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 41-3, burim-ro 170beon-gil, dongan-gu, gyeonggi-do, anyang South Korea Price Target Changed • Feb 12
Price target decreased by 10% to ₩30,500 Down from ₩34,000, the current price target is an average from 4 analysts. New target price is 41% above last closing price of ₩21,600. Stock is down 23% over the past year. The company is forecast to post earnings per share of ₩1,845 for next year compared to ₩1,603 last year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩350 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (1.4%). Price Target Changed • Nov 12
Price target decreased by 9.3% to ₩34,000 Down from ₩37,500, the current price target is an average from 4 analysts. New target price is 50% above last closing price of ₩22,650. Stock is down 21% over the past year. The company is forecast to post earnings per share of ₩1,843 for next year compared to ₩1,603 last year. Buy Or Sell Opportunity • Oct 25
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.2% to ₩24,300. The fair value is estimated to be ₩31,089, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 22% in 2 years. Earnings are forecast to grow by 58% in the next 2 years. Tillkännagivande • Jul 05
Vieworks Co., Ltd. Showcases High-Resolution Cameras at Vision China Shanghai 2024 Vieworks Co., Ltd. is to exhibit at Vision China Shanghai 2024 from July 8th to 10th (Booth E1.1600). Vieworks will be showcasing industrial cameras, industrial lenses, machine vision accessories, and X-ray flat panel detectors. Renowned for their ultra high resolution cameras, Vieworks will introduce VP-288MX2, thermoelectric Pelter cooled area scan camera with a remarkable 288 megapixel resolution. Vieworks' area scan cameras are suitable for demanding applications including flat panel inspection, printed circuit board inspection, and semiconductor inspection. Vieworks will also showcase VTS Series, the latest addition to their TDI (time delayed integration) line scan camera lineup. Equipped with BSI (back-side illuminated) sensors, VTS Series cameras offer enhanced quantum efficiency (QE) and signal-to-noise ratio (SNR). BSI sensors allow for greater sensitivity and ensure superior image quality in visible, UV, and NIR imaging, making VTS Series cameras particularly suitable for low-light environments. Vieworks' TDI line scan cameras—VT Series, VTS Series, and VTC Series—are available in M42, M58, M72, and M95 mounts from 2k to 23k resolution. Along with industrial cameras, VEO Series lenses will be displayed at the booth. VEO Series is a family of industrial lenses codeveloped with Schneider Kreuznach, precisely optimized for Vieworks' cameras. A live demo of VEO 10.0x lens with Vieworks camera and autofocus module will be operated. Industrial X-ray flat panel detectors will also be showcased. Vieworks will introduce their latest innovation in industrial X-ray imaging—bendable detectors. Unlike flat panel detectors, bendable detectors allow for non-destructive inspection of pipes and other objects that require flexibility. Diverse demonstrations on Vieworks' cameras and lenses will be showcased at the booth. Demos include display panel inspection with ultra high resolution 288 megapixel camera and printed circuit board inspection using 9k TDI line scan camera with HDR (high dynamic range) function. For TDI line scan, there will be a demonstration on how Vieworks' backside-illuminated VTS Series compares with frontside-illuminated TDI line scan. Reported Earnings • Mar 26
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: ₩1,603 (down from ₩2,890 in FY 2022). Revenue: ₩220.3b (down 7.4% from FY 2022). Net income: ₩14.7b (down 45% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.8%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Medical Equipment industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 8% per year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩700 per share at 2.6% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 12 April 2024. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.6%). Upcoming Dividend • Dec 21
Upcoming dividend of ₩750 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 2.5%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (1.8%). Tillkännagivande • Nov 24
Vieworks Exhibits At RSNA 2022 with Its Complete Lineup of Next Generation X-Ray Flat Panel Detectors Vieworks will be exhibiting its complete lineup of DR flat panel detectors (FPD) and dynamic FPDs at RSNA 2022 (South Hall #1723) from November 27th to November 30th. Celebrating the FDA-approval of VIVIX-S F series, the latest and most advanced line of Vieworks' FPDs, Vieworks will highlight its fully commercialized 3rd generation FPDs (VIVIX-S V series and VIVIX-S F series). Dynamic FPDs employing both a-Si and IGZO panel technology and mammography FPDs are also a must-see at Vieworks' booth. This year, Vieworks will be introducing its other imaging solutions – machine vision and bioimaging – at RSNA. VIVIX-S V and F series are both Vieworks' 3rd generation detectors offered in 3 sizes - 25x30cm (VIVIX-S 2530VW/FW), 36x43cm (VIVIX-S 3643VW/FW), and 43x43cm (VIVIX-S 4343VW/FW). VIVIX-S V series offers a cost-effective total solution, which the users can enjoy a high-definition, fast workflow, and the most durable DR detectors at a reasonable price. VIVIX-S F series offers a premium experience for users in terms of its finest image quality (pixel pitch: 99?), durability (unbreakable glass-free TFT), and usability (lighter weight, long-lasting battery). Vieworks also proudly presents the latest imaging software for each application. For static FPDs, Vieworks is displaying it's AI solution for chest x-ray diagnosis support. VIVIX-S F series' semi-dynamic feature that can bring new clinical values to the medical imaging field (e.g. tomosynthesis imaging and dual energy imaging) will be highlighted. Visitors will also get a glimpse of the latest updates on PureImpact Dynamic, imaging solution for dynamic detectors. Price Target Changed • Nov 18
Price target decreased to ₩50,000 Down from ₩55,000, the current price target is an average from 2 analysts. New target price is 57% above last closing price of ₩31,850. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,171 for next year compared to ₩3,575 last year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 1 independent director (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Price Target Changed • Jul 30
Price target increased to ₩65,000 Up from ₩55,000, the current price target is provided by 1 analyst. New target price is 59% above last closing price of ₩40,950. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₩3,654 for next year compared to ₩3,575 last year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 1 independent director (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩450 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 19 April 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (0.7%). Tillkännagivande • Sep 19
Vieworks to Showcase Its Complete Dental Detector Lineup At International Dental Show 2021 Vieworks presents its complete dental detector lineups at the International Dental Show (IDS) 2021 from 22 to 25 September. IDS is the world's biggest trade fair for dentistry and dental technology, which takes place in Cologne, Germany every two years. More than 160,000 visitors from 64 countries visited IDS 2019. At IDS, Vieworks will present its two dental detector series: VIVIX-D series, dynamic flat panel detectors, and VIVIX-C series, CMOS line sensor detectors. VIVIX-D series is a perfect solution for all-in-one dental CBCT and panoramic imaging. It is offered with both a-Si technology and IGZO technology, the latest TFT panel which has been emerging as a core technology in the dental field. VIVIX-C series is Vieworks' latest series which employs CMOS line sensor for high-precision panoramic imaging. In the end, based on the novel technology from Vieworks, dentists can enhance their daily workflow and provide high-quality patient care. In addition, Vieworks' network all around the world offers immediate customer service on time. VIVIX-D series with IGZO TFT: For dental CBCT and panoramic imaging; Available in 3 sizes (10 17 cm, 17 17 cm, and 17 24 cm); Supreme image quality with high resolution and SNR, and low image lag; Enhanced workflow with reliable image acquisition and transfer powered by Safe™; VIVIX-C series with CMOS line sensor. For dental panoramic imaging: Available in 2 sizes (15 1 cm and 23 * 1 cm); Sharp panoramic image quality even at a lower dose; Enhanced user convenience with onboard image correction and simple SDK API. Tillkännagivande • Aug 21
Vieworks Co., Ltd. (KOSDAQ:A100120) announces an Equity Buyback for KRW 5,000 million worth of its shares. Vieworks Co., Ltd. (KOSDAQ:A100120) announces a share repurchase program. Under the program, the company will repurchase KRW 5,000 million worth of its shares pursuant to a trust contract with Samsung Securities Co., Ltd. The purpose of the program is to enhance shareholder value and to stabilize stock price. The program will expire on August 19, 2021. As of August 19, 2021, the company had 578,927 shares in treasury within scope available for dividend and had no shares in treasury under other capacities. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment improved over the past week After last week's 15% share price gain to ₩42,400, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Medical Equipment industry in South Korea. Total returns to shareholders of 36% over the past three years. Price Target Changed • May 09
Price target increased to ₩50,000 Up from ₩42,400, the current price target is provided by 1 analyst. New target price is 31% above last closing price of ₩38,100. Stock is up 3.0% over the past year. Tillkännagivande • Feb 27
Vieworks Co., Ltd., Annual General Meeting, Mar 26, 2021 Vieworks Co., Ltd., Annual General Meeting, Mar 26, 2021, at 10:00 Korea Standard Time. Is New 90 Day High Low • Feb 17
New 90-day high: ₩35,200 The company is up 21% from its price of ₩29,050 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Medical Equipment industry, which is up 11% over the same period. Is New 90 Day High Low • Jan 21
New 90-day high: ₩32,650 The company is up 11% from its price of ₩29,450 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Medical Equipment industry, which is up 9.0% over the same period. Is New 90 Day High Low • Jan 06
New 90-day high: ₩32,000 The company is up 5.0% from its price of ₩30,550 on 08 October 2020. The South Korean market is up 24% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Medical Equipment industry, which is also up 5.0% over the same period. Is New 90 Day High Low • Oct 23
New 90-day low: ₩29,450 The company is down 17% from its price of ₩35,450 on 24 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩47,796 per share. Tillkännagivande • Sep 22
Vieworks Renews VL Series, High-Performance and Cost-Effective Line Scan Cameras Vieworks' VL Series, first launched in 2014, has been reintroduced to the machine vision industry with more powerful features but still at an affordable price. VL-8K and VL-16K, the two models in VL Series, deliver maximum line rates of 80 kHz and 40 kHz, respectively, offering users to speed up their inspection systems. VL Series provides the best solution to those seeking to upgrade their machine vision systems using multiple cameras such as flat panel display inspection, printed circuit board inspection, and high-performance document scanning. With resolution up to 16k and superior line rate up to 80 kHz, VL Series offers a cost-effective solution for inspection systems with greater speed than ever before. VL Series uses linear CMOS sensor and Camera Link interface. VL Series is designed in a compact size to help users to flexibly integrate them into machine vision systems with multiple cameras. Aside from widely used M72 mount, F-mount is also provided upon request. Cable connection can be extended up to 30m at 40MHz with Vieworks' VLink, link repeater. VL-8K model offers a wide range of image mode options, enabling customers to find the image mode that best suits their inspection systems. Available image modes include single line for low sensitivity, dual line for high sensitivity, horizontal binning, vertical binning, and H&V binning. Features: CMOS Linear Scan Sensor; Up to 80 kHz at 8k Resolution /Up to 40 kHz at 16k Resolution; CMOS Dual Line Scan Technology (VL-8K7C-M80F-2); 100x Anti-blooming; Exposure Control; Pre-emphasis Function; Programmable User Setting Commands. Applications: Flat Panel Display Inspection; Printed Circuit Board Inspection; High Performance Document Scanning; Printing and Packaging System. 
